Results 41 to 50 of about 227,935 (279)

Timely adoption of newer evidences

open access: yesBhutan Health Journal, 2021
How can such evidences help patients and the health system in Bhutan? Bhutan has a three-tiered health system that guides resource allocation such as the availability of medicines, testing facilities and placement of doctors.
Thinley Dorji
doaj   +1 more source

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs [PDF]

open access: yes, 2011
Background This study aimed to investigate existing trialling activity relating to three antipsychotic drugs from the WHO List of Essential Medicines (chlorpromazine, fluphenazine decanoate, haloperidol), link existing trials to existing Cochrane reviews,
Marianna Purgato   +2 more
core   +1 more source

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists [PDF]

open access: yesPLOS ONE, 2019
Non-communicable diseases (NCDs) are the leading cause of death worldwide. Inadequate and inequitable access to essential NCD medicines is a major concern, particularly in low- and middle-income countries. National Essential Medicines Lists (EMLs) are important policy tools that indicate which medicines are prioritized as essential within a country's ...
Jordan D. Jarvis   +4 more
openaire   +4 more sources

The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa [PDF]

open access: yes, 2016
The fast-track registration policy of the South African National Department of Health allows for rapid registration of new medicines of public health importance and of all medicines on the Essential Medicines List, most of which are generics. No limit is
Leng, HMJ, Pollock, AM, Sanders, D
core   +3 more sources

Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe [PDF]

open access: yes, 2018
International ...
Gandra, S   +6 more
core   +3 more sources

Can NGOs Regulate Medicines Markets? Social Enterprise in Wholesaling, and Access to Essential Medicines. [PDF]

open access: yes, 2011
Citizens of high income countries rely on highly regulated medicines markets. However low income countries' impoverished populations generally struggle for access to essential medicines through out-of-pocket purchase on poorly regulated markets; results ...
Chaudhuri, Sudip   +2 more
core   +4 more sources

Comparison of essential medicines lists in 137 countries

open access: yesBulletin of the World Health Organizatino, 2019
To compare the medicines included in national essential medicines lists with the World Health Organization's (WHO's) Model list of essential medicines, and assess the extent to which countries' characteristics, such as WHO region, size and health care expenditure, account for the differences.We searched the WHO's Essential Medicines and Health Products
Persaud N.   +17 more
openaire   +3 more sources

A systematic review and meta-analysis of noradrenaline compared to adrenaline in the management of septic shock

open access: yesAfrican Journal of Emergency Medicine
Background: Septic shock is associated with significant mortality. The International Surviving Sepsis Campaign guidelines recommend noradrenaline as first-line vasopressor, whilst South African guidelines recommend adrenaline.
Trudy D Leong   +8 more
doaj   +1 more source

Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers

open access: yesJCO Global Oncology, 2020
PURPOSE Improving access to essential medicines is necessary to reduce global mortality resulting from childhood cancer. However, there is a lack of context-specific data in many low- to middle-income countries on the determinants of access to essential ...
Brandon Tang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy